Tender detail
Open house drug discount contracts for the active substance Clobetasol, ATC D07AD01
Summary
The tender concerns non-exclusive drug discount contracts for the active substance Clobetasol (ATC D07AD01), implemented under an open-house model for the period 01 November 2026 to 31 October 2028, with the possibility of contract conclusion at any time. Medicines listed as pediatric medicines under the BfArM list are excluded.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.